- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
STJ Market Currents
more »
-
May 14 St. Jude Medical (STJ +2.1%) ticks higher after being upgraded to Buy at Goldman. The firm cites share gains in its core markets and entrance into new therapeutic categories, which could accelerate revenue growth through 2015. It also raises its price target to $50 from $45.
Comment![Healthcare, On the Move]
STJ in Focus
more »
STJ Related Articles
more »
STJ News
more »
-
at MarketWatch.com (May 14, 2012)
-
at CNBC.com (May 14, 2012)
-
at CNBC.com (Apr 18, 2012)
-
at MarketWatch.com (Apr 18, 2012)
-
at MarketWatch.com (Apr 17, 2012)
STJ Press Releases and Filings
more »
-
Business Wire (May 16, 2012)
-
Business Wire (May 16, 2012)
-
Business Wire (May 15, 2012)
-
Business Wire (May 15, 2012)
-
Business Wire (May 14, 2012)
STJ Latest Transcript
more »
-
Wed, Apr 18
STJ Cramer
more »
-
Thu, Apr 28, 2011
-
Sun, Mar 13, 2011
-
Thu, Mar 25, 2010
STJ Instablog posts
more »
STJ vs. ETF Alternatives
Company Description
St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. Our four operating... More
